METHOD FOR EVALUATING COMPOUNDS OR AGENTS FOR THEIR POTENTIAL TO INDUCE A PROLONGED QT INTERVAL ON THE ELECTROCARDIOGRAM OF A SUBJECT

Details for Australian Patent Application No. 2003222123 (hide)

Owner AVENTIS PHARMACEUTICALS INC.

Inventors RAMPE, David

Pub. Number AU-A-2003222123

PCT Number PCT/US03/09741

PCT Pub. Number WO2003/083487

Priority 0224018.2 16.10.02 GB; 60/368,755 29.03.02 US

Filing date 28 March 2003

Wipo publication date 13 October 2003

International Classifications

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 0224018.2 16.10.02 GB; 60/368,755 29.03.02 US

20 November 2003 Application Open to Public Inspection

  Published as AU-A-2003222123

16 December 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003222124-INTEGRATION OF AVIONICS SUBSYSTEMS INTO COCKPIT MULTIFUNCTIONAL DISPLAYS

2003222122-SYSTEMS AND METHODS FOR PIPELINE REHABILITATION